Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NST for Refractory Crohn's Disease
NCT01288053Phase 2Terminated
- Sponsor
- Northwestern University
- Start
- Jan 2010
- Primary completion
- Jun 2016
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of allogeneic hematopoietic stem cells in Crohn's disease, sponsored by Northwestern University. Started Jan 2010; status: terminated.
02
Drugs
allogeneic hematopoietic stem cells
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01288053.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01288053.